Chinese Academy of Sciences Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2014
NCT02277145
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Institute of Medicine and Biotechnology, Chinese Academy of Medical Sciences | Taizhou Hospital, Affiliated Cancer Hospital of the University of Chinese Academy of Sciences | The Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CAMS)